Interim analysis of a phase 2 minimal residual disease (MRD)-adaptive trial of elotuzumab, carfilzomib, lenalidomide, and dexamethasone (Elo-KRd) for newly diagnosed multiple myeloma (MM). This is an ...

A single-center observational study of more than 1,000 oncological examinations has demonstrated that positron emission tomography/magnetic resonance imaging (PET/MRI) facilitates cancer staging as ...

Post-neoadjuvant therapy changes in metabolic metrics from PET/MRI and morphologic metrics from CT were associated with pathologic response and overall survival in patients with pancreatic ductal ...

Various imaging modalities show low sensitivity for detecting pelvic lymph node invasion prior to surgery in patients with intermediate risk prostate cancer.

A novel imaging approach— 68 Ga-DOTATATE PET/CT—can more accurately differentiate residual/recurrent tumors from post-surgery scar tissue in patients with head and neck paragangliomas (HNPGLs) ...

Fluorine-18 prostate-specific membrane antigen (PSMA)-1007 PET/CT improves locoregional staging compared with MRI in patients undergoing surgery for intermediate and high-risk prostate cancer. PSMA ...

Two medical imaging breakthroughs have been presented at the Society of Nuclear Medicine and Molecular Imaging 2020 Virtual Annual Meeting. The technological advances demonstrate a PET/MRI approach to ...

Please provide your email address to receive an email when new articles are posted on . A 68-year-old woman initially presented with intermittent abdominal pain and persisting left hip pain. She gave ...

—Recently,PET-CT was designated as the gold standard for evaluating response to treatment and identifying patients with elevated risks of disease progression or premature death. Reviewed by Chaitra ...

Novel PET radiotracers have shown great potential in the early diagnosis and staging of PCa, detection of post-treatment recurrence, and monitoring of metastases not previously possible with current ...